Demonstrates enhanced osteoblast adhesive responses through specific vitronectin fragments, suggesting new targets for bone tissue engineering.
Vitronectin is a key extracellular matrix glycoprotein, but the functional contribution of specific residues within its N-terminal region to osteoblast activity remains poorly defined. We engineered a recombinant N-terminal fragment of human vitronectin (rVn-FI; residues 20-149) and performed a comprehensive mapping study using 16 overlapping 12-mer peptides to pinpoint the exact bioactive motifs. rVn-FI significantly promoted adhesion, spreading, and migration in HOS and MG-63 osteoblast-like cells, mediated primarily by αvβ3 and αvβ5 integrins. Peptide mapping revealed that two RGD-containing motifs-Vn-FI-P6 (AECKPQVTRGDV) and Vn-FI-P7 (PQVTRGDVFTMP)-were the sole drivers of this activity. Notably, Vn-FI-P7 exhibited a significantly higher inhibitory potency against cell adhesion to vitronectin than Vn-FI-P6, suggesting that the flanking sequences in Vn-FI-P7 provide a superior conformational context for integrin binding. None of the other 14 peptides showed biological activity, confirming the absence of non-RGD-dependent binding sites within the N-terminal fragment (residues 20-149). These results define the precise functional boundaries of the vitronectin N-terminus for osteoblast interaction. Our findings highlight that the flanking sequences in Vn-FI-P7 provide a superior conformational context for RGD-integrin binding, offering specific peptide targets for enhancing the bioactivity of bone tissue engineering scaffolds.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: